Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2021-10-01 00:00:00 ET · period of report 2021-09-29 · accession 0001209191-21-058556 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-01 | 2021-09-29 | ACAD | GAROFALO ELIZABETH A. | Dir | M - OptEx | — | +1,918 | 1,918 | New | — |
| D | 2021-10-01 | 2021-09-29 | ACAD | GAROFALO ELIZABETH A. | Dir | M - OptEx | $0.00 | +1,918 | 1,919 | +191,800% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-29 | M | A | 1,918 | — | 1,918 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. |
| 2 | Derivative | Restricted Stock Units | 2021-09-29 | M | A | 1,918 | $0.00 | 1,919 | D | — · — to — | 1,918 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. (F2) The restricted stock units shall vest in two equal annual installments commencing September 29, 2021. |